Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2021-04-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房内部控制审计报告
Regulatory Filings
2021-04-27 Chinese
益丰药房关于向银行申请综合授信额度并接受关联方提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding its application for a comprehensive credit facility from multiple banks and the acceptance of guarantees from a related party. It details the credit limits requested, the banks involved, the guarantee provided by the controlling shareholder, and the independent directors' opinion on the transaction. The document is short (1375 characters) and focuses on financing activities, specifically credit facilities and guarantees. It does not contain financial statements or detailed financial results, nor is it a report or presentation. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2021-04-27 Chinese
益丰药房2020年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2020 年年度报告" which translates to "2020 Annual Report". It contains detailed financial data, company business overview, management statements, auditor's report mention, profit distribution plans, risk disclosures, and comprehensive financial and operational information. The length is substantial (15,000 characters) and it includes actual financial statements and analysis, not just an announcement or summary. The presence of auditor's unqualified opinion and detailed financial metrics confirms it is the full official annual report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2020
2021-04-27 Chinese
益丰药房2020年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised by the company through non-public issuance of A shares and public issuance of convertible bonds for the fiscal year 2020. It includes specifics on amounts raised, usage, balances, project investment details, changes in investment projects, and compliance with regulatory requirements. The document references regulatory approvals from the China Securities Regulatory Commission and Shanghai Stock Exchange rules, and includes attachments with detailed tables on fund usage and project progress. The content focuses exclusively on the management and use of raised capital funds, which aligns with a Capital/Financing Update. It is not an annual report, earnings release, or audit report, nor is it a brief announcement or a certification. The length and detail confirm it is a full report rather than a publication announcement. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2021-04-27 Chinese
益丰药房关于使用部分闲置自有资金购买理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Yifeng Pharmacy Chain Co., Ltd. regarding the use of part of its idle funds to purchase financial products. It details the board meeting decision, investment purpose, amount, risk control measures, and recent usage of funds for financial products. The document includes financial data but is primarily focused on informing shareholders and the public about a financing activity related to the company's capital management, specifically the use of idle funds for purchasing low-risk financial products. It is not a full financial report, audit, or earnings release, nor is it a regulatory certification or voting result. The document fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage.
2021-04-27 Chinese
益丰药房2020年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2020 Annual Report Summary" of Yifeng Pharmacy Chain Co., Ltd. It contains detailed financial data for the year 2020, including net profit, total assets, revenue, earnings per share, and other key financial indicators. It also discusses business operations, industry analysis, company strategy, and shareholder information. The length of the document (13,720 characters) and the presence of comprehensive financial and operational data indicate this is a full annual report rather than a brief announcement or summary. The document is not a certification, announcement, or presentation but a detailed report covering the company's yearly performance and outlook. Therefore, it fits the definition of an Annual Report (10-K). FY 2020
2021-04-27 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.